Stonehaven Cozmix Group (SC Group)
Marian-Adrian Grosu is currently a Partner at Stonehaven Cozmix Group (SC Group), leading the Stonehaven Data & Analytics division with a focus on the lifescience space, particularly in Animal Health. Prior to this, they have held various leadership roles at Novartis, including Executive Director at Novartis Oncology and Director of Global Pharma Strategy. Grosu also has a background in consulting, having worked at McKinsey & Company and Deloitte. They hold a PhD in Business Administration and Management, along with an MBA with a concentration in Finance.
Stonehaven Cozmix Group (SC Group)
Stonehaven Cozmix Group (SC Group) is a global life sciences management consultancy firm that serves innovative life sciences companies at various phases of development. The company was created upon the merger of Stonehaven Consulting AG and Cozmix Inc. Cozmix was founded in 2005 and has successfully advised life science clients in commercial resource allocation with their proprietary tools and software suite. Stonehaven Consulting was established in 2015 and has since then delivered numerous strategy projects for clients in animal health, human health, and private equity.